AVN : stem cell treatment Patient suffering from bilateral Avn cured through Stem Cell therapy. By: StemRx BioScience … Continue reading →

PUBLIC RELEASE DATE: 29-Jan-2014 Contact: Steffanie Marchese steffanie.marchese@autismspeaks.org 646-385-8537 Autism Speaks NEW YORK, N.Y. (January 29, 2014) A new study from researchers at Autism Speaks, the world's leading autism science and advocacy organization, shows improvement towards universal early screening for autism. The report, published online today in the Journal of the American Academy of Child and Adolescent Psychiatry, also found that few approaches to early detection, such as screening during well-child visits, were evaluated to understand their impact on early diagnosis and access to services. The study, which identified and examined 40 previously published studies on programs for early detection of ASD and 35 various approaches, found the need for a multipronged approach in assessing children for autism in order to increase early detection. These findings raise concerns about whether current methods are enough to reduce the average age of autism diagnosis and increase access to high-quality early intervention. Early intervention is crucial for enhancing the development of communication, learning and social skills in children with autism. "The good news is that we found universal screening for autism risk to be feasible and practical," says lead author Amy Daniels, Autism Speaks assistant director for public health research. "We also see … Continue reading →

Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today. Professor Gregory Y.H. Lip, lead author of the European Society of Cardiology (ESC) study, said: "The perception that aspirin is a safe and effective drug for preventing strokes in AF needs to be dispelled. If anything, you could say that giving aspirin to patients with AF is harmful because it is minimally or not effective at stroke prevention, yet the risk of major bleeding or intracranial haemorrhage is not significantly different to well-managed oral anticoagulation." He added: "All the contemporary guidelines1 say that aspirin should not be used for the prevention of stroke in patients with AF. And yet our study shows that aspirin is still overprescribed in these patients." Stroke prevention is central to the management of patients with AF. As the most common cardiac rhythm disorder, AF occurs in 1.5-2% of the general population in the developed world and people over the age of 40 have a 1 in 4 lifetime risk of developing AF.2 Patients with AF have a five-fold risk of stroke, and when they do have strokes they lead to more death … Continue reading →

PUBLIC RELEASE DATE: 28-Jan-2014 Contact: ESC Press Office press@escardio.org 33-049-294-7756 European Society of Cardiology Sophia Antipolis, 28 January 2014: Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today. Professor Gregory Y.H. Lip, lead author of the European Society of Cardiology (ESC) study, said: "The perception that aspirin is a safe and effective drug for preventing strokes in AF needs to be dispelled. If anything, you could say that giving aspirin to patients with AF is harmful because it is minimally or not effective at stroke prevention, yet the risk of major bleeding or intracranial haemorrhage is not significantly different to well-managed oral anticoagulation." He added: "All the contemporary guidelines1 say that aspirin should not be used for the prevention of stroke in patients with AF. And yet our study shows that aspirin is still overprescribed in these patients." Stroke prevention is central to the management of patients with AF. As the most common cardiac rhythm disorder, AF occurs in 1.5-2% of the general population in the developed world and people over the age of 40 have a 1 in 4 lifetime risk of developing AF.2 Patients … Continue reading →